Introduction
re-expansion, death, dyspnea, fatigue, fever, excessive pulmonary secretion, viral pneumonia, lower respiratory tract illness, cough, atelectatic, disability, EPS, breathlessness, muscular and aerobic systems deterioration, coronavirus infection pneumonia, acute respiratory distress syndrome
ACUTE RESPIRATORY DISEASE, COVID-19 PNEUMONIA, DISEASE, VIRAL PNEUMONIA, ACUTE RESPIRATORY DISTRESS SYNDROME, COMPLICATIONS
In late December 2019, the coronavirus infection pneumonia epidemic broke out and rapidly spread worldwide [Patients with COVID-19 can present influenza-like signs and symptoms like fever (89%), cough (68%), fatigue (38%), excessive pulmonary secretion (EPS) or sputum (34%), and breathlessness (19%). The disease can appear asymptomatic or mild lower respiratory tract illness through severe viral pneumonia with acute respiratory distress syndrome and even death [Pulmonary physiotherapy (PPT) is a comprehensive therapeutic method that is aimed to improve patient’s respiratory symptoms, train effective cough, clear the airways, decrease symptoms of dyspnea, re-expansion pf atelectatic lung, provide short-term improvement in lung-thorax compliance, reduce the complications related to disease, minimize disability and finally improve the health-related quality of life (HRQOL) [Up to now, some studies with different designs and levels of evidence have been suggested PPT strategies for hospitalized patients with various stages of COVID-19 pneumonia [Although some researchers and expert clinicians suggested that early PPT can be tailored in the condition of acute respiratory disease to prevent further muscular and aerobic systems deterioration, helping the therapeutic process, decrease hospitalization duration, and facilitate future recovery in patients with COVID-19 [